Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

A Heather Eliassen, Sc.D.

Co-Author

This page shows the publications co-authored by A Eliassen and David Hunter.
Connection Strength

1.543
  1. Population Attributable Risk of Modifiable and Nonmodifiable Breast Cancer Risk Factors in Postmenopausal Breast Cancer. Am J Epidemiol. 2016 12 15; 184(12):884-893.
    View in: PubMed
    Score: 0.180
  2. Use of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and risk of breast cancer among premenopausal women in the Nurses' Health Study II. Arch Intern Med. 2009 Jan 26; 169(2):115-21; discussion 121.
    View in: PubMed
    Score: 0.104
  3. Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment. Breast Cancer Res. 2021 Aug 18; 23(1):86.
    View in: PubMed
    Score: 0.062
  4. Mendelian randomisation study of smoking exposure in relation to breast cancer risk. Br J Cancer. 2021 Aug 02.
    View in: PubMed
    Score: 0.062
  5. Risk of Breast Cancer Among Carriers of Pathogenic Variants in Breast Cancer Predisposition Genes Varies by Polygenic Risk Score. J Clin Oncol. 2021 Aug 10; 39(23):2564-2573.
    View in: PubMed
    Score: 0.061
  6. Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers. Nat Commun. 2021 May 14; 12(1):2986.
    View in: PubMed
    Score: 0.061
  7. Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer Risk. J Natl Cancer Inst. 2021 03 01; 113(3):329-337.
    View in: PubMed
    Score: 0.060
  8. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers. Nat Commun. 2021 02 17; 12(1):1078.
    View in: PubMed
    Score: 0.060
  9. CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers. Br J Cancer. 2021 02; 124(4):842-854.
    View in: PubMed
    Score: 0.060
  10. Breast Cancer Risk Factors and Survival by Tumor Subtype: Pooled Analyses from the Breast Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev. 2021 04; 30(4):623-642.
    View in: PubMed
    Score: 0.060
  11. Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk. Sci Rep. 2020 06 16; 10(1):9688.
    View in: PubMed
    Score: 0.057
  12. A network analysis to identify mediators of germline-driven differences in breast cancer prognosis. Nat Commun. 2020 01 16; 11(1):312.
    View in: PubMed
    Score: 0.056
  13. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer. NPJ Breast Cancer. 2019; 5:38.
    View in: PubMed
    Score: 0.055
  14. Genome-wide association study of germline variants and breast cancer-specific mortality. Br J Cancer. 2019 03; 120(6):647-657.
    View in: PubMed
    Score: 0.052
  15. PAM50 Molecular Intrinsic Subtypes in the Nurses' Health Study Cohorts. Cancer Epidemiol Biomarkers Prev. 2019 04; 28(4):798-806.
    View in: PubMed
    Score: 0.052
  16. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes. Am J Hum Genet. 2019 01 03; 104(1):21-34.
    View in: PubMed
    Score: 0.052
  17. Molecular mechanisms linking high body mass index to breast cancer etiology in post-menopausal breast tumor and tumor-adjacent tissues. Breast Cancer Res Treat. 2019 Feb; 173(3):667-677.
    View in: PubMed
    Score: 0.051
  18. A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer. Nat Genet. 2018 07; 50(7):968-978.
    View in: PubMed
    Score: 0.050
  19. Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer. Nat Genet. 2017 Dec; 49(12):1767-1778.
    View in: PubMed
    Score: 0.048
  20. Association analysis identifies 65 new breast cancer risk loci. Nature. 2017 11 02; 551(7678):92-94.
    View in: PubMed
    Score: 0.048
  21. Alcohol consumption and breast tumor gene expression. Breast Cancer Res. 2017 Sep 12; 19(1):108.
    View in: PubMed
    Score: 0.047
  22. A comprehensive survey of genetic variation in 20,691 subjects from four large cohorts. PLoS One. 2017; 12(3):e0173997.
    View in: PubMed
    Score: 0.046
  23. Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations. Cancer Res. 2016 09 01; 76(17):5103-14.
    View in: PubMed
    Score: 0.043
  24. Interactions between breast cancer susceptibility loci and menopausal hormone therapy in relationship to breast cancer in the Breast and Prostate Cancer Cohort Consortium. Breast Cancer Res Treat. 2016 Feb; 155(3):531-40.
    View in: PubMed
    Score: 0.042
  25. Teenage acne and cancer risk in US women: A prospective cohort study. Cancer. 2015 May 15; 121(10):1681-7.
    View in: PubMed
    Score: 0.039
  26. Plasma carotenoid- and retinol-weighted multi-SNP scores and risk of breast cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. Cancer Epidemiol Biomarkers Prev. 2013 May; 22(5):927-36.
    View in: PubMed
    Score: 0.035
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.